ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.95326
0.06%
Brent Oil
84.265
0.87%
Bitcoin
57,657.66
-1.00%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) Noticias

INO Inovio Pharmaceuticals Inc New

11.59
0.00 (0.00%)
Pre Mercado
Última actualización: 03:01:46
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Inovio Pharmaceuticals Inc New INO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 11.59 03:01:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.59
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
29/4/202407:00PRNUSINOVIO to Participate in Upcoming Investor Conferences in..
15/4/202417:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
26/3/202417:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
06/3/202415:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202406:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/3/202405:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
21/2/202407:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
07/2/202410:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
02/2/202407:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
31/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202415:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/1/202415:02EDGAR2Form 8-K - Current report
23/1/202407:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
22/1/202407:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
12/1/202416:27EDGAR2Form 8-K - Current report
04/1/202407:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/1/202407:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
28/11/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202315:00EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202315:35EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202315:15EDGAR2Form 8-K - Current report
09/11/202315:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:01EDGAR2Form 8-K - Current report
01/11/202307:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
26/10/202307:00PRNUSINOVIO to Report Third Quarter 2023 Financial Results on..
10/10/202315:00EDGAR2Form 8-K - Current report
10/10/202309:51DJNInovio Shares Rise 8% After FDA Feedback for INO-3107
10/10/202307:00PRNUSINOVIO Receives FDA Feedback that Data from Completed Phase..
27/9/202318:39PRNUSGeneos Therapeutics Closes its Series A3 Financing With..
07/9/202307:00PRNUSINOVIO Announces U.S. FDA Breakthrough Therapy Designation..
29/8/202307:00PRNUSINOVIO to Present at the H.C. Wainwright 25th Annual Global..
09/8/202315:23EDGAR2Form 8-K - Current report
09/8/202315:05PRNUSINOVIO Announces Second Quarter 2023 Financial Results and..
09/8/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202307:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
31/7/202320:43EDGAR2Form 8-K - Current report
26/7/202308:32PRNUSINOVIO to Report Second Quarter 2023 Financial Results on..
07/7/202315:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/7/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/6/202315:10GLOBEINOVIO Announces Notice of Pendency and Proposed Settlement..
01/6/202307:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
25/5/202307:00PRNUSINOVIO to Present at the 2023 Jefferies Healthcare..
23/5/202315:13PRNUSINOVIO Announces Orphan Drug Designation for INO-3107 for..
10/5/202315:05PRNUSINOVIO Reports First Quarter 2023 Financial Results and..
08/5/202307:00PRNUSNew Data from Phase 1/2 Trial of INO-3107 for the Treatment..
05/5/202307:00PRNUSINOVIO to Present at the 2023 RBC Capital Markets Global..

Su Consulta Reciente

NASDAQ
INO
Inovio Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados